US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 151.430
  • -4.430-2.84%
Close Apr 1 16:00 ET
  • 152.850
  • +1.420+0.94%
Post 16:26 ET
9.10BMarket Cap-21.44P/E (TTM)

Ascendis Pharma A/S Key Stats

Ascendis Pharma A/S Q4 2024 Earnings Date

Currency:EURFeb 12, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
119.60M
173.92M
+54.32M
Beat Est.
-13.15%
+26.30%
+45.42%
EPS
-1.17
-0.64
+0.53
Beat Est.
+23.96%
+58.44%
+45.35%
Strong Buy

Apr 1, 2025

Ascendis Pharma A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 125.611M--
--2025/Q1-- / 93.986M--
Feb 12, 20252024/Q4173.916M / 119.596M--
Nov 14, 20242024/Q357.833M / 70.312M--
Sep 3, 20242024/Q235.998M / 84.468M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 125.611M--
--2025/Q1-- / 93.986M--
Feb 12, 20252024/Q4173.916M / 119.596M--
Nov 14, 20242024/Q357.833M / 70.312M--
Sep 3, 20242024/Q235.998M / 84.468M--

Unlock Free Earnings Estimates

Ascendis Pharma A/S Earnings Reports

Read more

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More